Skip to Main content Skip to Navigation
Journal articles

2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer

Abstract : Despite the clinical success of Androgen Receptor (AR)-targeted therapies, reactivation of AR signalling remains the main driver of castration-resistant prostate cancer (CRPC) progression. In this study, we perform a comprehensive unbiased characterisation of LNCaP cells chronically exposed to multiple AR inhibitors (ARI). Combined proteomics and metabolomics analyses implicate an acquired metabolic phenotype common in ARI-resistant cells and associated with perturbed glucose and lipid metabolism. To exploit this phenotype, we delineate a subset of proteins consistently associated with ARI resistance and highlight mitochondrial 2,4-dienoyl-CoA reductase (DECR1), an auxiliary enzyme of beta-oxidation, as a clinically relevant biomarker for CRPC. Mechanistically, DECR1 participates in redox homeostasis by controlling the balance between saturated and unsaturated phospholipids. DECR1 knockout induces ER stress and sensitises CRPC cells to ferroptosis. In vivo, DECR1 deletion impairs lipid metabolism and reduces CRPC tumour growth, emphasizing the importance of DECR1 in the development of treatment resistance.
Document type :
Journal articles
Complete list of metadatas

Cited literature [84 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02880147
Contributor : Myriam Bodescot <>
Submitted on : Wednesday, June 24, 2020 - 4:17:51 PM
Last modification on : Wednesday, November 25, 2020 - 5:06:04 PM

File

s41467-020-16126-7.pdf
Publication funded by an institution

Identifiers

Collections

Citation

Arnaud Blomme, Catriona Ford, Ernest Mui, Rachana Patel, Chara Ntala, et al.. 2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer. Nature Communications, Nature Publishing Group, 2020, 11 (1), pp.2508. ⟨10.1038/s41467-020-16126-7⟩. ⟨inserm-02880147⟩

Share

Metrics

Record views

55

Files downloads

149